HCA Healthcare, Inc. (NYSE:HCA) Stake Lowered by HB Wealth Management LLC

HB Wealth Management LLC lessened its position in HCA Healthcare, Inc. (NYSE:HCA) by 13.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,930 shares of the company’s stock after selling 624 shares during the period. HB Wealth Management LLC’s holdings in HCA Healthcare were worth $1,180,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Terra Nova Asset Management LLC grew its stake in shares of HCA Healthcare by 0.3% in the 3rd quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock worth $3,297,000 after purchasing an additional 26 shares during the last quarter. Massmutual Trust Co. FSB ADV increased its position in HCA Healthcare by 7.4% in the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock worth $171,000 after purchasing an additional 29 shares during the last quarter. Waldron Private Wealth LLC grew its position in HCA Healthcare by 1.8% in the third quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock worth $683,000 after acquiring an additional 29 shares in the last quarter. Brookstone Capital Management raised its holdings in HCA Healthcare by 0.7% during the third quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock valued at $1,652,000 after buying an additional 30 shares in the last quarter. Finally, UMB Bank n.a. lifted its stake in shares of HCA Healthcare by 2.4% in the third quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock worth $529,000 after buying an additional 30 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Up 0.4 %

Shares of NYSE HCA opened at $310.60 on Tuesday. The company has a 50 day simple moving average of $316.69 and a 200 day simple moving average of $353.19. HCA Healthcare, Inc. has a 1 year low of $278.50 and a 1 year high of $417.14. The firm has a market cap of $78.68 billion, a PE ratio of 13.95, a price-to-earnings-growth ratio of 1.03 and a beta of 1.64. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, December 27th. Investors of record on Friday, December 13th were paid a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 0.85%. The ex-dividend date was Friday, December 13th. HCA Healthcare’s dividend payout ratio is presently 11.85%.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on HCA shares. KeyCorp cut their price target on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a report on Tuesday, January 7th. Truist Financial dropped their target price on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a report on Monday, January 6th. TD Cowen dropped their price objective on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a report on Monday, October 28th. Raymond James downgraded shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. Finally, Morgan Stanley cut their price target on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research note on Tuesday, December 17th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $385.27.

Insider Transactions at HCA Healthcare

In other news, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the transaction, the insider now directly owns 6,843 shares of the company’s stock, valued at $2,415,579. This represents a 29.76 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the transaction, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.70% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.